BioLineRx Reports Year End 2017 Financial Results

Go back to BioLineRx Reports Year End 2017 Financial Results
Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

Bioline RX Ltd Ordinary shares (AMEX: BLNEF) Delayed: 0.86 --0 (-0%)
Previous Close $0.86    52 Week High $1.54 
Open $1.64    52 Week Low $1.15 
Day High $0.86    P/E N/A 
Day Low $0.86    EPS $0.00 
Volume 1,500       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.13 -0.13 (3.99%)
Previous Close $3.26    52 Week High $1.63 
Open $3.20    52 Week Low $0.71 
Day High $3.37    P/E N/A 
Day Low $3.10    EPS $0.00 
Volume 21,391       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.13 -0.13 (3.99%)
Previous Close $3.26    52 Week High $1.63 
Open $3.20    52 Week Low $0.71 
Day High $3.37    P/E N/A 
Day Low $3.10    EPS $0.00 
Volume 21,391       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.13 -0.13 (3.99%)
Previous Close $3.26    52 Week High $1.63 
Open $3.20    52 Week Low $0.71 
Day High $3.37    P/E N/A 
Day Low $3.10    EPS $0.00 
Volume 21,391       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 3.13 -0.13 (3.99%)
Previous Close $3.26    52 Week High $1.63 
Open $3.20    52 Week Low $0.71 
Day High $3.37    P/E N/A 
Day Low $3.10    EPS $0.00 
Volume 21,391